387 related articles for article (PubMed ID: 34202494)
1. Amyotrophic Lateral Sclerosis: Molecular Mechanisms, Biomarkers, and Therapeutic Strategies.
Yang X; Ji Y; Wang W; Zhang L; Chen Z; Yu M; Shen Y; Ding F; Gu X; Sun H
Antioxidants (Basel); 2021 Jun; 10(7):. PubMed ID: 34202494
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis.
Thompson AG; Gray E; Thézénas ML; Charles PD; Evetts S; Hu MT; Talbot K; Fischer R; Kessler BM; Turner MR
Ann Neurol; 2018 Feb; 83(2):258-268. PubMed ID: 29331073
[TBL] [Abstract][Full Text] [Related]
3. CSF chitinase proteins in amyotrophic lateral sclerosis.
Thompson AG; Gray E; Bampton A; Raciborska D; Talbot K; Turner MR
J Neurol Neurosurg Psychiatry; 2019 Nov; 90(11):1215-1220. PubMed ID: 31123140
[TBL] [Abstract][Full Text] [Related]
4. Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
Verde F; Otto M; Silani V
Front Neurosci; 2021; 15():679199. PubMed ID: 34234641
[TBL] [Abstract][Full Text] [Related]
5. Exosomal TAR DNA-binding protein-43 and neurofilaments in plasma of amyotrophic lateral sclerosis patients: A longitudinal follow-up study.
Chen PC; Wu D; Hu CJ; Chen HY; Hsieh YC; Huang CC
J Neurol Sci; 2020 Nov; 418():117070. PubMed ID: 32836016
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs in amyotrophic lateral sclerosis: from pathogenetic involvement to diagnostic biomarker and therapeutic agent development.
Wang L; Zhang L
Neurol Sci; 2020 Dec; 41(12):3569-3577. PubMed ID: 33006054
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid MFG-E8 as a promising biomarker of amyotrophic lateral sclerosis.
Yang B; Wu Y; Wang Y; Yang H; Du B; Di W; Xu X; Shi X
Neurol Sci; 2020 Oct; 41(10):2915-2920. PubMed ID: 32338335
[TBL] [Abstract][Full Text] [Related]
8. Modeling hallmark pathology using motor neurons derived from the family and sporadic amyotrophic lateral sclerosis patient-specific iPS cells.
Sun X; Song J; Huang H; Chen H; Qian K
Stem Cell Res Ther; 2018 Nov; 9(1):315. PubMed ID: 30442180
[TBL] [Abstract][Full Text] [Related]
9. Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression.
Steinacker P; Verde F; Fang L; Feneberg E; Oeckl P; Roeber S; Anderl-Straub S; Danek A; Diehl-Schmid J; Fassbender K; Fliessbach K; Foerstl H; Giese A; Jahn H; Kassubek J; Kornhuber J; Landwehrmeyer GB; Lauer M; Pinkhardt EH; Prudlo J; Rosenbohm A; Schneider A; Schroeter ML; Tumani H; von Arnim CAF; Weishaupt J; Weydt P; Ludolph AC; Yilmazer Hanke D; Otto M;
J Neurol Neurosurg Psychiatry; 2018 Mar; 89(3):239-247. PubMed ID: 29142138
[TBL] [Abstract][Full Text] [Related]
10. Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis.
Gille B; De Schaepdryver M; Goossens J; Dedeene L; De Vocht J; Oldoni E; Goris A; Van Den Bosch L; Depreitere B; Claeys KG; Tournoy J; Van Damme P; Poesen K
Neuropathol Appl Neurobiol; 2019 Apr; 45(3):291-304. PubMed ID: 29908069
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease.
Gaiani A; Martinelli I; Bello L; Querin G; Puthenparampil M; Ruggero S; Toffanin E; Cagnin A; Briani C; Pegoraro E; Sorarù G
JAMA Neurol; 2017 May; 74(5):525-532. PubMed ID: 28264096
[TBL] [Abstract][Full Text] [Related]
12. Advances and challenges in understanding the multifaceted pathogenesis of amyotrophic lateral sclerosis.
Laferriere F; Polymenidou M
Swiss Med Wkly; 2015; 145():w14054. PubMed ID: 25635517
[TBL] [Abstract][Full Text] [Related]
13. Silence superoxide dismutase 1 (SOD1): a promising therapeutic target for amyotrophic lateral sclerosis (ALS).
Abati E; Bresolin N; Comi G; Corti S
Expert Opin Ther Targets; 2020 Apr; 24(4):295-310. PubMed ID: 32125907
[No Abstract] [Full Text] [Related]
14. MicroRNA Metabolism and Dysregulation in Amyotrophic Lateral Sclerosis.
Rinchetti P; Rizzuti M; Faravelli I; Corti S
Mol Neurobiol; 2018 Mar; 55(3):2617-2630. PubMed ID: 28421535
[TBL] [Abstract][Full Text] [Related]
15. New molecular diagnostic trends and biomarkers for amyotrophic lateral sclerosis.
Pampalakis G; Mitropoulos K; Xiromerisiou G; Dardiotis E; Deretzi G; Anagnostouli M; Katsila T; Rentzos M; Patrinos GP
Hum Mutat; 2019 Apr; 40(4):361-373. PubMed ID: 30556231
[TBL] [Abstract][Full Text] [Related]
16. Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS).
Volkening K; Leystra-Lantz C; Yang W; Jaffee H; Strong MJ
Brain Res; 2009 Dec; 1305():168-82. PubMed ID: 19815002
[TBL] [Abstract][Full Text] [Related]
17. Identification of Regulatory Factors and Prognostic Markers in Amyotrophic Lateral Sclerosis.
Sun H; Li M; Ji Y; Zhu J; Chen Z; Zhang L; Deng C; Cheng Q; Wang W; Shen Y; Shen D
Antioxidants (Basel); 2022 Feb; 11(2):. PubMed ID: 35204186
[TBL] [Abstract][Full Text] [Related]
18. Enteroviral Infection: The Forgotten Link to Amyotrophic Lateral Sclerosis?
Xue YC; Feuer R; Cashman N; Luo H
Front Mol Neurosci; 2018; 11():63. PubMed ID: 29593492
[TBL] [Abstract][Full Text] [Related]
19. Amyotrophic Lateral Sclerosis Model.
Azuma Y; Mizuta I; Tokuda T; Mizuno T
Adv Exp Med Biol; 2018; 1076():79-95. PubMed ID: 29951816
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in understanding amyotrophic lateral sclerosis and emerging therapies.
Gittings LM; Sattler R
Fac Rev; 2020; 9():12. PubMed ID: 33659944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
